Schwarz Pharma AG - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Schwarz Pharma AG Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Schwarz Pharma AG. The Group's principal activity is to research, develop, manufacture and market pharmaceuticals. It involves in bulk manufacturing, packaging and material management of pharmaceutical drugs. It specializes in manufacturing solid oral dosage forms and packing with modern blister machines. It also provides raw material and packaging materials for pharmaceutical industries. The drugs are manufactured for the following concerns: Cardiovascular diseases, Gastro intestinal diseases, Urology and Central nervous system related diseases. It operates under the brand names Atmadisc, Deponit, Dycanil, Elantan, Firin, Harzol, Isoket, Naramig, Nipruss and Sita. The Group operates in Germany, Italy, the United Kingdom, the United States, Switzerland, China, Hong Kong and Philippines.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report